Not sure if this has already been posted somewhere. It gives a little more information on timing of the trial for the COVID-19 / ARDS trial and expected read out of information along the way:
https://www.nasdaq.com/articles/can-mesoblasts-covid-19-treatment-increase-survival-rate-analyst-dives-in-2020-04-27
"The study is expected to initiate imminently, and management expects to complete patient enrollment in three months. An interim readout is expected at the completion of enrollment of one third of the planned study population."
Published 27 April 27 2020 6:25PM EDT
Not sure if this has already been posted somewhere. It gives a...
-
- There are more pages in this discussion • 15,864 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |